Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alanyl-Glutamine for Post-Myomectomy Adhesions
NCT01701193Phase 2Completed
- Sponsor
- Temple Therapeutics
- Start
- Feb 2015
- Primary completion
- Oct 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alanyl glutamine in Pelvic adhesions, sponsored by Temple Therapeutics. Started Feb 2015; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
Pelvic adhesions
Beyond the preview
Go deeper on NCT01701193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701193.